Label-Free Proteomics Approach Characterizes Plasma Protein Signature of Donor Brain Death

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/313828

Lähdeviite

Lukac , J , Saraswat , M , Holmström , E , Dhaygude , K , Joenväärä , S , Krebs , R , Nykänen , A , Renkonen , R & Lemström , K 2019 , ' Label-Free Proteomics Approach Characterizes Plasma Protein Signature of Donor Brain Death ' , Journal of Heart and Lung Transplantation , vol. 38 , no. 4, Supplement , pp. S159 . https://doi.org/10.1016/j.healun.2019.01.380

Julkaisun nimi: Label-Free Proteomics Approach Characterizes Plasma Protein Signature of Donor Brain Death
Tekijä: Lukac, J.; Saraswat, Mayank; Holmström, E.; Dhaygude, K.; Joenväärä, Sakari; Krebs, R.; Nykänen, A.; Renkonen, R.; Lemström, K.
Tekijän organisaatio: HUSLAB
Doctoral Programme in Biomedicine
Clinicum
Department of Pathology
Doctoral Programme in Wildlife Biology
Transplantation Laboratory
HUS Heart and Lung Center
Staff Services
Department of Bacteriology and Immunology
Risto Renkonen / Principal Investigator
Infection Biology Research Program
Department of Surgery
University Management
Doctoral Programme in Clinical Research
Päiväys: 2019-04
Kieli: eng
Sivumäärä: 1
Kuuluu julkaisusarjaan: Journal of Heart and Lung Transplantation
ISSN: 1053-2498
DOI-tunniste: https://doi.org/10.1016/j.healun.2019.01.380
URI: http://hdl.handle.net/10138/313828
Tiivistelmä: Purpose Despite recent advances in donation after circulatory death, transplants from brain-dead donors remain the sole source in heart transplantation (HTx) worldwide. Due to organ shortage, marginal donors are increasingly used and the utilization of transplants becomes markedly more challenging. They undergo invariably brain death that induces a systemic cytokine and catecholamine storm that lead to systemic inflammation, labile hemodynamics, and organ hypoperfusion. Together, these can damage the heart and aggravate later occurring graft injury, and ultimately, compromise graft function. However, the effect of donor brain death on allografts is not well understood. Methods In a separate prospective, blinded single-center trial, we collected donor plasma samples and relevant clinical patient data from 50 HTx brain-dead donors and as controls plasma samples from age- and gender-matched 23 healthy volunteers. Quantitative label-free proteomics in high definition MSE mode (HDMSE) was carried out on the samples. Various statistical analyses were performed on quantitative proteomics data to obtain the most reliably distinguishing proteins, which classify the donors vs controls. Results With two or more unique proteins per identification, 463 proteins were quantified in our pilot study. A complete separation between donors and controls based on a set of 278 proteins (p-value
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by_nc_nd
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: acceptedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
abstract_Lukac_ISHLT2019_final_draft.pdf 179.4KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot